1. Home
  2. USNA vs PBYI Comparison

USNA vs PBYI Comparison

Compare USNA & PBYI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo USANA Health Sciences Inc.

USNA

USANA Health Sciences Inc.

N/A

Current Price

$14.34

Market Cap

397.1M

Sector

Health Care

ML Signal

N/A

Logo Puma Biotechnology Inc

PBYI

Puma Biotechnology Inc

N/A

Current Price

$9.52

Market Cap

467.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
USNA
PBYI
Founded
1992
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
397.1M
467.2M
IPO Year
1996
2011

Fundamental Metrics

Financial Performance
Metric
USNA
PBYI
Price
$14.34
$9.52
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
177.0K
261.3K
Earning Date
05-05-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.08
Revenue
$1,060,902,000.00
$27,685,000.00
Revenue This Year
$3.90
N/A
Revenue Next Year
$6.21
N/A
P/E Ratio
N/A
$115.13
Revenue Growth
N/A
N/A
52 Week Low
$12.57
$4.30
52 Week High
$31.15
$9.74

Technical Indicators

Market Signals
Indicator
USNA
PBYI
Relative Strength Index (RSI) 45.84 53.75
Support Level $12.57 $8.78
Resistance Level $15.75 $9.55
Average True Range (ATR) 0.62 0.36
MACD 0.31 -0.06
Stochastic Oscillator 62.20 45.03

Price Performance

Historical Comparison
USNA
PBYI

About USNA USANA Health Sciences Inc.

Usana Health Sciences Inc develops and manufactures high-quality nutritional supplements, functional foods, and personal care products that are sold throughout the world. The company has developed and manufactured high-quality, science-based nutritional, personal care, and skincare products with a primary focus on promoting long-term health and wellness. The Company's reporting units for goodwill purposes are tied to its reportable segments: Core nutritional and Hiya direct-to-consumer. The core nutritional segment consists of three individual reporting units that are determined based on the operational nature of the business: Buy-Sell, China, and India. Geographically, it is in Asia Pacific, the Americas, and Europe. With the majority of revenue from Asia Pacific(Greater China).

About PBYI Puma Biotechnology Inc

Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes inventive products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also, it is developing Alisertib, a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis, resulting in apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.

Share on Social Networks: